Marco Baron Toaldo

In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis

Francesca Fornari, Daniela Pollutri, Clarissa Patrizi et al. · Clinical Cancer Research · 2017 · 172 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease

Marco Baron Toaldo, Giovanni Romito, Carlo Guglielmini et al. · Journal of Veterinary Internal Medicine · 2018 · 62 citations · Full text

Medicine, Cardiology, Veterinary Diagnostic Imaging +17

Use of VEGFR-2 Targeted Ultrasound Contrast Agent for the Early Evaluation of Response to Sorafenib in a Mouse Model of Hepatocellular Carcinoma

Marco Baron Toaldo, Veronica Salvatore, Sara Marinelli et al. · Molecular Imaging and Biology · 2014 · 59 citations

Medicine, Oncology, Pharmacology +17

DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study

Michele Borgarelli, Luca Ferasin, Kenneth Lamb et al. · Journal of Veterinary Cardiology · 2020 · 55 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma

Catia Giovannini, Michele Baglioni, Marco Baron Toaldo et al. · Oncotarget · 2013 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17